O. Kanat And H. Ertas, "Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy," WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2, pp.52-61, 2019
Kanat, O. And Ertas, H. 2019. Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy. WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2 , 52-61.
Kanat, O., & Ertas, H., (2019). Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy. WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2, 52-61.
Kanat, Ozkan, And Hulya Ertas. "Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy," WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2, 52-61, 2019
Kanat, Ozkan And Ertas, Hulya. "Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy." WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2, pp.52-61, 2019
Kanat, O. And Ertas, H. (2019) . "Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy." WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.2, pp.52-61.
@article{article, author={Ozkan Kanat And author={Hulya Ertas}, title={Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy}, journal={WORLD JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={52-61} }